Prenetics Global Stock (NASDAQ:PRE)


RevenueOwnershipFinancialsChart

Previous Close

$5.64

52W Range

$2.85 - $7.84

50D Avg

$4.71

200D Avg

$5.02

Market Cap

$68.17M

Avg Vol (3M)

$13.64K

Beta

-0.21

Div Yield

-

PRE Company Profile


Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

320

IPO Date

Jul 16, 2021

Website

PRE Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22
HONG KONG$12.92M$210.93M
Rest Of The World$1.18M-
TAIWAN$9.33M-

Fiscal year ends in Dec 23 | Currency in USD

PRE Financial Summary


Dec 23Dec 22Dec 21
Revenue$21.74M$275.76M$275.85M
Operating Income$-52.51M$207.42M$-10.35M
Net Income$-62.72M$-190.45M$-174.02M
EBITDA$-51.08M$43.22M$-162.44M
Basic EPS$-5.58$-37.57$-14.77
Diluted EPS$-5.58$-37.57$-14.77

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
SERASera Prognostics, Inc.
QGENQiagen N.V.
ACRSAclaris Therapeutics, Inc.
CSTLCastle Biosciences, Inc.
DRIODarioHealth Corp.
BDSXBiodesix, Inc.
XGNExagen Inc.
BNRBurning Rock Biotech Limited
NOTVInotiv, Inc.
NEOGNeogen Corporation
FONRFONAR Corporation
MDXHMDxHealth SA